Logo-ijhpm
Int J Health Policy Manag. 2022;11(9): 1695-1702. doi: 10.34172/ijhpm.2021.74
PMID: 34380194        PMCID: PMC9808222

Original Article

Smoke-Free Policies and 30-Day Mortality Rates for Chronic Obstructive Pulmonary Disease

Hanadi Hamadi 1 * ORCID, Sericea Stallings-Smith 1 ORCID, Emma Apatu 2 ORCID, Breck Peterson 1, Aaron Spaulding 3 ORCID

Cited by CrossRef:

1- Feng L, Lv X, Wang Y, Chu S, Dai Z, Jing H, Tong Z, Liao X, Liang L. Developments in smoking cessation interventions for patients with chronic obstructive pulmonary disease in the past 5 years: a scoping review. Expert Review of Respiratory Medicine. 2022;16(7):749 [Crossref]
2- Shen S, Xiao Y. Association Between C-Reactive Protein and Albumin Ratios and Risk of Mortality in Patients with Chronic Obstructive Pulmonary Disease. COPD. 2023;Volume 18:2289 [Crossref]